Demographics (3)
- AGE - Subject age at enrollment (phv00496019.v1.p1)
- COLLECTION_AGE - Age sample was collected (phv00496026.v1.p1)
- SEX - Biological sex (phv00496014.v1.p1)
Disease Events (2)
- AFFECTION_STATUS - Case control status of the subject for gastrointestinal cancers (phv00496018.v1.p1)
- KRAS - Somatic mutation in KRAS (Entrez GeneID: 3845) (phv00496020.v1.p1)
Other (15)
- ANALYTE_TYPE - Analyte Type (phv00496023.v1.p1)
- BODY_SITE - Body site where sample was collected (phv00496022.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00496013.v1.p1)
- HISTOLOGICAL_TYPE - Cell or tissue type or subtype of sample (phv00496025.v1.p1)
- IS_TUMOR - Tumor status (phv00496024.v1.p1)
- PRIMARY_METASTATIC_TUMOR - Primary tumor, metastasis, or transformed cell line (phv00496027.v1.p1)
- PRIMARY_TUMOR_LOCATION - Primary tumor location (phv00496028.v1.p1)
- SAMPLE_ID - Sample ID (phv00496021.v1.p1)
- SAMPLE_ID - Sample ID (phv00496016.v1.p1)
- SUBJECT_ID - Subject ID (phv00496017.v1.p1)
- SUBJECT_ID - Subject ID (phv00496012.v1.p1)
- SUBJECT_ID - Subject ID (phv00496015.v1.p1)
- TUMOR_GRADE - Tumor grade of sample (phv00496030.v1.p1)
- TUMOR_STAGE - Tumor stage of sample (phv00496029.v1.p1)
- TUMOR_TREATMENT - Type of tumor treatment for sample (phv00496031.v1.p1)